Observe and understand

The research,
clearly explained.

Here we share laboratory observations, the methods used and source documents. Take your time to explore them at your own pace.

The observations

What was measured

Exploratory work studies the M.I.D.™ material under laboratory conditions.

The context

What these results tell us

The observations described apply to the conditions of each experiment. They are not clinical evidence or a guarantee of individual results.

The journey

How we moved from experience to evidence.

The story is simple. We listened to users, then looked for measurable signals that could help explain why O-Mira exists.

01

Early users in France noticed a real difference

They reported feeling less drained after hours of scrolling, emails or work, and a more comfortable relationship with their phone.

02

O‑Mira wanted to understand why.

Instead of turning experience into exaggerated claims, we looked for measurable signals.

03

ENERLAB analysed it.

Independent laboratory work observed measurable changes in human blood and plasma samples exposed to the M.I.D.™ material.

04

The French Alternative Energies and Atomic Energy Commission (CEA) confirmed a change.

Tests on blood samples conducted at the CEA showed measurable changes consistent with ENERLAB’s observations.

Independent analysis

Measured by ENERLAB.

For O-Mira, laboratory work is not about making medical promises. It is about understanding whether the M.I.D.™ material is associated with measurable changes in biological signals under controlled conditions, and whether these changes can be observed again through a separate confirmation process.

Initial independent analysis.

The initial analyses were carried out by ENERLAB, an independent laboratory in France, using human blood and plasma samples.

The observations focused on ultra-weak biological light emission, also known as ultra-weak photon emission, a faint signal studied in biological systems.

O-Mira presents this as a process of measurement and confirmation, not as a medical claim or institutional endorsement.

The expert

Olivier Salières has devoted his career to studying biophotons, the ultra-weak light emitted by living systems.
He designed and built his own measuring instruments, among the very few of their kind worldwide.
Today, his analyses are sought after by elite athletes and recognised names in fine dining.

Officially registered

ENERLAB is a registered French laboratory.
It is listed with INSEE, RNE and INPI, the official French state registries.
SIREN 938 817 624. Anyone can verify this at any time.

Fully independent

ENERLAB does not sell O-Mira. We do not own ENERLAB.
We funded the analysis, not the results.
Our most important findings were also tested at the CEA, the French Alternative Energies and Atomic Energy Commission, with consistent results.
Same samples, same protocol: the material either produces an effect or it does not.

Understanding the measurements

Read the source data, not just the headline figure.

Each chart below shows the original image from the study, alongside a plain-language guide to the measurement, comparison and observed trend.

Chart 01

Biophoton emission over time

A day-by-day view of ultra-weak light emission in plasma and whole blood samples, measured from 29 April to 7 May 2026.

How to read this chart

This heat map shows the amount of ultra-weak biophoton light emitted by each sample each day. Each row represents plasma or whole blood, measured with or without O-Mira. Yellow indicates higher emission; green and blue indicate lower emission; dark purple indicates 0 RLU, meaning no detectable signal.

What the data show

  1. At the first measurement, the O-Mira samples were noticeably brighter: plasma measured 702 RLU versus 286 RLU without O-Mira, while whole blood measured 723 RLU versus 316 RLU without O-Mira.
  2. Signals decreased over time in all samples. However, the O-Mira conditions remained detectable for longer: plasma until 5 May and whole blood until 6 May — the last sample still emitting.

Source: ENERLAB biophoton study on blood and plasma, 2026.

Chart 02

Photon signal remodulation

A four-day comparison of ultra-weak photon emission from water exposed to an active mobile phone, measured with and without O-Mira.

How to read this chart

This study measured ultra-weak photon emission from 100 ml of tap water exposed to an active mobile phone. Without O-Mira, the dominant signal was detected in the 300–400 nm band. With the O-Mira device, it appeared in the 400–500 nm band. Results are expressed in RLU. The dark chamber, empty tube and water-only controls remained below the study’s noise threshold of 50 RLU throughout the protocol.

What the data show

  1. Over four consecutive days, the phone + water condition produced a very stable average of 753.9 RLU, with dominant emission in the 300–400 nm band. After adding O-Mira, the signal averaged 549.5 RLU and was consistently detected in the 400–500 nm band.
  2. This represents a 27.1% reduction in average intensity and a complete shift from near ultraviolet to visible blue. Photon energy decreased from approximately 3.54 eV to 2.76 eV per photon — a lower-energy spectral regime interpreted in the report as consistent with more organised electron-transfer dynamics.

Source: ENERLAB biophoton study on phones, water and O-Mira, 2026.

ENERLAB research archive

Want to explore the full study?

Access the full ENERLAB research report for a detailed view of the protocol, measurements, results and their scientific interpretation.



Analysis of phone-related signals and water
Additional report 2026

Analysis of phone-related signals and water

Biophoton signal measurements in a water-based phone exposure model, with O-Mira present.

This additional report examines how the measured photon signal changed in a controlled water model linked to phone-related electromagnetic exposure.

  • Phone signal
  • Water model
  • Biophoton
  • Spectral profile
Open the PDF Research PDF


Biophoton study on alfalfa germination
Additional report 2026

Biophoton study on alfalfa germination

Comparative monitoring of photon emission during alfalfa germination under the O-Mira research protocol.

This report tracks germination-related photon activity over time and compares the O-Mira condition with a matched control group.

  • Germination
  • Alfalfa
  • Plant model
  • Biophoton
Open the PDF Research PDF


Study on bean seed germination
MEZAGRI REPORT 2026

Study on bean seed germination

Evaluation of the germination rate of seeds pre-exposed to O‑MIRA, compared with an untreated control batch.

Conducted by the MEZAGRI laboratory, this trial involves 40 bean seeds divided into two batches of 20. The monitoring, carried out from 17 to 25 August 2026, compares seed germination between the two experimental conditions.

  • Germination
  • BEAN
  • Plant model
  • COMPARATIVE TRIAL
Open the PDF Research PDF

M.I.D.™ MATERIAL TECHNOLOGY

The research is only beginning.

Bring M.I.D.™ technology into your everyday relationship with your phone with O-Mira One.

Choose O-Mira One

Selected library

Biophoton research goes far beyond O-Mira.

For decades, some of the world’s most recognised scientists and laboratories have studied ultra-weak photon emissions. These twelve scientific references offer a broader foundation for understanding the field and placing O-Mira’s results in context.

Index view: UPE, human body, oxidative stress, spectroscopy, PubMed identifiers
12 sources
2009 Human rhythm

Imaging of ultra-weak spontaneous photon emission from the human body displaying diurnal rhythm.

Kobayashi M.; Kikuchi D.; Okamura H. PLoS ONE.

Why it matters: A landmark study showing that the body emits ultra-weak light below the sensitivity threshold of the naked eye, with rhythmic daily variation.

PMID: 19606225 DOI: 10.1371/journal.pone.0006256
View on PubMed
2005 Human overview

An introduction to human biophoton emission.

Van Wijk R.; Van Wijk E.P. Forsch Komplementarmed Klass Naturheilkd.

Why it matters: A useful starting point for understanding biophoton emission as ultra-weak light from living systems, including humans.

PMID: 15947465 DOI: 10.1159/000083763
View on PubMed
2021 Non-invasive tool

Human ultra-weak photon emission as a non-invasive spectroscopic tool for diagnosis of internal states: a review.

Zapata F.; Pastor-Ruiz V.; Ortega-Ojeda F.; Montalvo G.; Ruiz-Zolle A.V. J Photochem Photobiol B.

Why it matters: Presents human UPE as a developing non-invasive research field, influenced by oxidative metabolic processes and internal or external factors.

PMID: 33540236 DOI: 10.1016/j.jphotobiol.2021.112141
View on PubMed
2014 Whole-body imaging

Towards whole-body ultra-weak photon counting and imaging with a focus on human beings: a review.

Van Wijk R.; Van Wijk E.P.; van Wietmarschen H.A.; van der Greef J. J Photochem Photobiol B.

Why it matters: Places human UPE research within systems biology and considers the body as a complex, dynamic biological system.

PMID: 24359911 DOI: 10.1016/j.jphotobiol.2013.11.014
View on PubMed
2016 Spectral analysis

Analysis of the polychromatic spectral patterns of ultra-weak photon emissions from the human body.

Kobayashi M.; Iwasa T.; Tada M. J Photochem Photobiol B.

Why it matters: Shows why wavelength profiles matter when interpreting UPE, beyond the total amount of light detected.

PMID: 27082276 DOI: 10.1016/j.jphotobiol.2016.03.037
View on PubMed
2014 Mechanisms

Ultra-weak photon emission from biological samples: definition, mechanisms, properties, detection and applications.

Cifra M.; Pospisil P. J Photochem Photobiol B.

Why it matters: An overview of the field covering the definition, detection and interpretation of UPE in biological samples.

PMID: 24726298 DOI: 10.1016/j.jphotobiol.2014.02.009
View on PubMed
2014 Cellular communication

New perspective on cell communication: the potential role of ultra-weak photon emission.

Prasad A.; Rossi C.; Lamponi S.; Pospisil P.; Foletti A. J Photochem Photobiol B.

Why it matters: Examines experimental findings and hypotheses about the possible contribution of ultra-weak emissions to communication between cells.

PMID: 24703082 DOI: 10.1016/j.jphotobiol.2014.03.004
View on PubMed
2020 Human skin

Oxidative stress in human facial skin observed by ultra-weak photon emission imaging and its correlation with the biophysical properties of skin.

Tsuchida K.; Kobayashi M. Scientific Reports.

Why it matters: Shows that UPE imaging can reveal regional variations in oxidative stress in human facial skin under controlled observation conditions.

PMID: 32541901 DOI: 10.1038/s41598-020-66723-1
View on PubMed
2023 Label-free imaging

Imaging of biological auto(chemi)luminescence of oxidative processes in human skin.

Poplova M.; Prasad A.; Van Wijk E.; Pospisil P.; Cifra M. Analytical Chemistry.

Why it matters: Shows how very weak luminescence can spatially distinguish oxidative processes in human skin without labelling.

PMID: 37753614 DOI: 10.1021/acs.analchem.3c01566
View on PubMed
2019 Skin assessment

Imaging of ultra-weak photon emission for evaluating oxidative stress of human skin.

Tsuchida K.; Iwasa T.; Kobayashi M. J Photochem Photobiol B.

Why it matters: Supports UPE imaging and spectroscopy as research methods for assessing oxidation-related skin responses.

PMID: 31349151 DOI: 10.1016/j.jphotobiol.2019.111562
View on PubMed
2010 Epidermal cells

Ultra-weak photon emission as a non-invasive tool for monitoring oxidative processes in human skin epidermal cells.

Rastogi A.; Pospisil P. Skin Research and Technology.

Why it matters: Describes spontaneous UPE as the result of cellular metabolic processes and as a signal for monitoring oxidative processes in skin research.

PMID: 20637006 DOI: 10.1111/j.1600-0846.2010.00442.x
View on PubMed
2010 Monitoring method

Using ultra-weak photon emission to determine the effect of oligomeric proanthocyanidins on oxidative stress in human skin.

Van Wijk E.P.; Van Wijk R.; Bosman S. J Photochem Photobiol B.

Why it matters: Presents UPE measurement as a non-invasive method for continuously monitoring oxidative stress responses in human skin research.

PMID: 20138538 DOI: 10.1016/j.jphotobiol.2010.01.003
View on PubMed